A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy

M. V. Holmes, R. S. Dawe, J. Ferguson, S. H. Ibbotson

    Research output: Contribution to journalArticle

    81 Citations (Scopus)

    Abstract

    Background Many patients find topical 5-aminolaevulinic acid (ALA) photodynamic therapy (PDT) painful. Local anaesthetics are not routinely used and their effect on PDT pain has not been examined.
    Objectives To evaluate the efficacy of tetracaine gel (Ametop) for pain relief during and after PDT.
    Methods A prospective, double-blind, placebo-controlled study of 42 patients with lesions (= 2 cm diameter) of superficial nonmelanoma skin cancer or dysplasia. Patients were randomized to either tetracaine (4% w / w) (n = 22) or vehicle (n = 20) gel under occlusion for 1 h pre-irradiation. Pain was assessed during and after irradiation using a visual analogue scale (VAS) and faces pain scale.
    Results Patients who received tetracaine gel experienced only slightly less pain during PDT (median VAS 4) compared with those who received placebo (median VAS 4.5) (95% confidence interval for difference 0–3, P=0.08). No significant difference in pain was experienced between the treatment groups immediately after irradiation or later.
    Conclusions When compared with placebo, tetracaine gel did not significantly reduce pain during or after PDT for small lesions of superficial basal cell carcinoma, Bowen’s disease or actinic keratosis.

    Original languageEnglish
    Pages (from-to)337-340
    Number of pages4
    JournalThe British journal of dermatology
    Volume150
    Issue number2
    DOIs
    Publication statusPublished - Feb 2004

      Fingerprint

    Keywords

    • Photosensitivity Disorders
    • Double-Blind Method
    • Humans
    • Photochemotherapy
    • Aged
    • Pain
    • Carcinoma, Basal Cell
    • Skin Neoplasms
    • Anesthetics, Local
    • Tetracaine
    • Bowen's Disease
    • Gels
    • Prospective Studies
    • Aged, 80 and over
    • Adult
    • Treatment Outcome
    • Middle Aged
    • Administration, Topical
    • Female
    • Male

    Cite this